Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Lung function in never smoking patients with alpha1antitrypsin deficiency

R.A. Stockley, R.G. Edgar
European Respiratory Journal 2013 42: P4709; DOI:
R.A. Stockley
1Lung Function and Sleep Department, University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R.G. Edgar
1Lung Function and Sleep Department, University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Introduction

Alpha-1-antitrypsin deficiency (AATD) is a recognised susceptibility factor for the development of COPD although the natural history in the absence of smoking is poorly documented.

Method

We assessed the FEV1 (% predicted) and Kco (% predicted) in 202 never smokers referred to the UK AAT database and compared the data to their age at assessment for individuals < and ≥ 45 years age.

Results

The patients age ranged from 16-76 years and a significant negative correlation was present for FEV1 vs. age (r=0.422; p<0.0001) and Kco vs. age (r=0.474; p<0.0001). Under the age of 45 (n=59) the average FEV1 was 106.1% predicted (SE 2.7) and was below the normal range in 6. The Kco was 92.4% predicted (± 1.9) and below the normal range in 10.

Over 45 years age (n=143) the average FEV1 was 76.7 ± 2.7% predicted and Kco was 69.4 ± 1.7% predicted. However 49.7% and 38.0% of patients still had FEV1 and Kco respectively within the normal range.

Conclusion

Although AATD influences lung function independently of smoking there is a wide range of impact on physiology which remains normal in many patients suggesting other epigenetic influences.

This poster was funded by an unlimited educational grant from Grifols.

  • COPD - diagnosis
  • COPD - mechanism
  • Physiology
  • © 2013 ERS
Previous
Back to top
Vol 42 Issue Suppl 57 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Lung function in never smoking patients with alpha1antitrypsin deficiency
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Lung function in never smoking patients with alpha1antitrypsin deficiency
R.A. Stockley, R.G. Edgar
European Respiratory Journal Sep 2013, 42 (Suppl 57) P4709;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Lung function in never smoking patients with alpha1antitrypsin deficiency
R.A. Stockley, R.G. Edgar
European Respiratory Journal Sep 2013, 42 (Suppl 57) P4709;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Should pseudomonas aeruginosa be the main target in bronchiectasis?
  • X-Tab: Non-interventional study to assess patient-related mid-term outcomes of omalizumab therapy in severe allergic asthmatic patients
  • Clinical Impact of Gensini score in chronic obstructive pulmonary disease (COPD)
Show more 5.2 Monitoring Airway Disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society